A mutant of mouse prion protein (Prp c ) carrying a deletion of residues 114-l21 (PrPA 114-121) has previously been described to lack convertibility into the scrapie-associated isoform ofPrP (PrP SC ) and to exhibit a dominant-negative effect on the conversion of wild-type Prp c into Prp sc in living cells. Here we report the characterization of recombinantly expressed PrPA1l4-121 by Fourier-transformation infrared spectroscopy (FTIR) and circular dichroism (CD) spectroscopy. The analysis of spectra revealed an increased antiparallel I>,-sheet content in the deletion mutant compared to wild-type Prp c . This additional short p,-sheet stabilized the fold of the mutant protein by A A GO/ = 3.4±O.3 kJ mol-I as shown by chemical unfolding experiments using guanidine hydrochloride. Secondary structure predictions suggest that the additional f3-sheet in PrP~1l4-l21 is close to the antiparallel f3-sheet in Prp c . The high-affinity Cu 2 +-bindirig site outside the octarepeats, which is located close to the deletion and involves HisllO as a ligand, was not affected, as detected by electron paramagnetic resonance (EPR) spectroscopy, suggesting that Cu 2 + binding does not contribute to the protection ofPrPA 114-121 from conversion into Prp sc . We propose that the deletion of re si dues 114-121 stabilizes the mutant protein. This stabilization most likely does not obstruct the interaction of PrP A 114-121 with Prp sc but represents an energy barrier that blocks the conversion of PrPA 114-l21 into Prp sc .
Introduction
Prions are the causative agents of transmissible spongiform encephalopathies [1] . These fatal neurodegenerative diseases include BSE in cattle, scrapie in sheep, and Creutzfeldt-Jakob disease (CJD) in humans, and can be of infectious or genetic etiology or arise spontaneously. They are characterized by the conversion of the cellular prion protein (Prp c ) into a diseaseassociated isoform (PrP addition to the membrane localization via the GPI anchor of Prp c , transmembrane topologies of Prp c have been described [10, 11] . These transmembrane forms are inserted into the lipid bilayer of the endoplasmic reticulum via the TM1 domain of Prp c , a hydrophobic stretch between residues 111 and 134, encompassing the highly conserved hydrophobic core AGAAAAGA (amino acids 112-119).
The first link between the TM 1 domain and prion disease became apparent by the fact that a peptide encompassing amino acids 106-126 (human numbering) induces neurotoxic effects in cultured primary brain cells [12] [13] [14] [15] .
Subsequently, it was shown that PrP mutants lacking the TMI domain or part of it are not converted into Prp sc [16] .
Specifically, murine PrP mutants with deletions of residues 114-121 [17] or 112-119 [18] are not converted into Prp sc . Moreover, the deletion of 114-121 (henceforth termed led to a reduction in the level ofPrp sc derived from endogenous Prp c -wt in scrapie-infected Neuro2a cells, i.e. the deletion mutant had a dominant-negative effect on Prp sc accumulation [17] . Recently, we investigated in a collaborative study the effect of in transgenic mice with respect to the physiological function of Prp c [19] . We could show that the PrP ~ 114-121 mutant was not intrinsically toxic in the presence or absence of Pr pC. Co-expression ofPrP~114-121 with other deletion mutants showed that it alleviates the pathogenic effect of the PrP~32-134 mutant, which is characterized by a spontaneous, non-infectious neurodegenerative syndrome distinct from prion disease. By contrast, PrP ~ 114-121, enhanced the pathogenic effect of the PrP~94-134 deletion mutant. In another study published simultaneously the effect ofPrP ~ 105-125 in transgenic mice was investigated [20] . Both studies concluded that Prp c acts neuroprotective via constitutive activation of a putative PrP receptor. Conversion of Prp c into Prp sc might disrupt the interaction between Prp c and the PrP receptor, although the detailed molecular mechanism is still unclear. Likewise, the mechanism underlying the inconvertibility ofPrP ~ 114-121 into Prp sc has not been resolved so far.
A key to fully understand the function of the TM 1 domain in PrP is the combination of data from different methodological approaches such as transgenic mice, cell biological model systems and biochemical structural studies. In this study we investigated the structural consequences of deleting residues 114-121 in murine Prp c .
Materials and methods

Plasmid construction
For recombinant protein expression, the cDNA of murine PrP coding for amino acids 23-230 was cloned into the E. coli expression vector pRSET A (Invitrogen) yielding pRSET A::PrP-wt. The expression vector for PrPa1l4-121, pRSET A::PrPAII4-121, was constructed by subcloning the fragment of PrPA1I4-121 obtained by digesting pUCI9::PrPAII4-121 [17) with Eco81I and Eco91I (MBI-Fermentas) into pRSET A::PrP-wt. The correct insertion was checked by DNA sequencing.
Recombinant protein expression and purification
PrP-wt and PrPa114-121 were expressed in E. coli BL21(DE3) as hexahistidine (His6)-tagged fusion proteins and purified to homogeneity as published previously [21) . Briefly, inclusion bodies of the recombinant protein were denatured and subjected to affinity chromatography on nickel-NTA agarose. The . protein was refolded and oxidized while immobilized on the column, followed . by elution with buffer containing imidazole. The His 6 -tag was then removed by thrombin cleavage. After ion-exchange chromatography, the protein was dialyzed against water and lyophilized. Purity was checked by SDS-PAGE.
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in D:;!O, pD 7.0. At least four spectra were recorded between 260 and 180 nm, averetged and corrected for the buffer spectrum. The secondary structure content ofPrPwt and PrPil114-121 was calculated by a least-square fit according to CharJg et a!. [23] implemented into the interface Dicroprot [24] , which uses a base Set of four CD spectra typical for each type of secondary stlUcture. FurtLtellnore the secondary structure content was assessed with the programs SELCON [25] , CONTINLL [26] and CDSSTR [27] using a base set of 43 CD spectra of proteins with known structure. The latter 3 programs are implemented in the interface CDPro [28] .
The stability of the protein against denaturation was assessed using guanidine hydrochloride (GdnHCI) by adding aIiquots of a 7 M GdnHCI stock SOlution (PH 6.0) to PrP-wt or PrPil114-121 (concentration: 15 f.lM, in 20 mM MES in D 2 0, pD 6.0) and measuring the eIIipticity at 222 nm. The values were recorded ten times and averaged. Assuming a two-state folding mechanism, the difference in free energy (il G) between folded and unfolded state is calculated according to Pace:
where R is the gas constant, T the absolute temperature and Fd the fraction of unfolded protein [29] . The data from the denaturation experiments were analyzed by a nonIinear least-square fit using the program Origin version 7.0 (Origin Lab).
FTIR spectroscopy
All measurements were performed in D 2 0, which does not adsorb in the region of the amide I transitions of the peptide backbone. Lyophilized PrP was dissolved in D 2 0. The pD was adjusted to 7.2 by addition of concentrated DCI or NaOH. The samples were equilibrated overnight at room temperature iil order to achieve complete proton-deuterium exchange of the backbone amides. The protein concentration was 150 flM throughout. Spectra were recorded at 293 K on a Bruker Tensor 27 FTIR spectrometer accumulating 128 scans at a resolution of 2 cm-I; spectra of D 2 0 were recorded under the same conditions and subtracted from the sample spectra. The position of individual IR transitions in the amide I' region between 1700 and 1600 cm-I was resolved by second order derivative spectra. For protein secondary structure analysis the spectra were fitted with a set of 8 Lorentzian line shaped transitions.
EPR spectroscopy
Spectra were recorded on a Bruker Elexsys 500 instrument, with the following settings: microwave frequency 9.34 GHz (X-band), microwave power 0.2-4 mW, modulation frequency 100 kHz, modulation amplitude I mT, temperature 22 K; 10 spectra between 240 and 380 mT were averaged for each sample. 
Results
Protein expression and purification
In order to characterize the consequences of deleting aa 114-121 for the structure of murine PrP, we expressed PrP-wt and PrPA114-121 in E. coli as recombinant proteins and purified them to homogeneity. The applied method for protein purification and refolding was shown to yield highly structurally homogenous protein preparations [21, 30, 31] . Both, PrP-wt and PrP A 114-121, contained the structurally essential disulfide bond and displayed comparable solubility.
Structural analysis of PrP-wt and PrPA114-121 by FTIR and CD spectroscopy
For the structural analysis of PrP-wt and PrPA 114-121 at pH 7.0, we applied FTIR spectroscopy to monitor amide If oscillations between 1700 and 1600 cm-I. The amide I band represents predominantly C=O and C-N vibrations of the peptide backbone that are sensitive towards the hydrogen bonding pattern and thereby reflect the different types of secondary structure. In D 2 0 the proton of the amide group is exchanged with the deuterium ion, and consequently the positions of the bands shift to smaller wavenumber (amide If band). The FTIR spectra of PrP-wt and PrPAl14-l21 had a very similar shape ( Fig. 2A, B ) except for the region around 1615 cm -1 (Fig. 2C ). The transition in this region is typical for antiparallel p,-sheets, and already suggested whigher content of antiparallel p,-sheets in PrP A 114-121. For a detailed analysis of the secondary structure content of PrP-wt and PrP A 114-121 Wavenumberl cm"1 Wavenumber I cm;1
Wavenurnber {cm"' the spectra were fitted by a set of 8 Lorentzian line shaped IR transitions (Fig. 2B) . Six out of 8 transitions could be assigned to contributions of (.~-helix (1652 cm-I), (,,>-sheet (1631 cm-I), turns (~1664 cm-1 and ~1676 cm-I), and random coil (1642 cm -I )( Table I) . Two bands at 1587 and 1564 cm -I were assigned to contributions of amino acid sidechains. Integration of the 6 bands revealed for both proteins a content of 22% ahelix, 25-28% f,-sheet, 17-18% ('',-turns, and 32-35% random coil (Table 1 ). The analysis revealed clearly a structural difference between PrP-wt and PrPIl114-121. PrP1l114-121 displayed a higher content of antiparallel as well as parallel 13- sheets and I:,>-tums and correspondingly a lower random content than PrP-wt.
In order to estimate the consequences of deleting residues 114-121 might have for the structure of PrP, we performed secondary structure predictions for the PrP peptides aa 100-150 and the corresponding deletion mutant by nnPredict [32] . The prediction for the wt peptide is in reasonable agreement with the structure of mouse PrP 121-231 as determined by NMR [33] . The first f,-sheet encompassing residues 128-131 is predicted by nnPredict and there is some propensity (Fig. 3) for an a-helix at the position of helix 1 (residues 144-153) of mouse PrP [33] . Furthermore, a long hydrophobic helix (108-119) is predicted in the TMl region (residues 111-134). This helix is present in PrP when it is inserted in the membrane, whereas PrP in solution does not show any secondary structure of this region at pH 4.5 1079 or pH 7.0 [34, 35] . The prediction for the corresponding peptide (PrP 100-150, 11114-121) suggests that the deletion eliminates the possibility of a-helix formation, but instead supports the formation of another short f)-sheet at residues 108-110. This short f)-sheet could align antiparallel to the existing f:'>-sheets and give rise to the observed signal in FTIR.
In order to substantiate the changes in secondary structure observed by FTIR spectroscopy, we recorded CD spectra of PrP-wt and PrP 11114-121 for secondary structure analysis (Fig.  4) . CD spectra were recorded between 180 and 260 nm, which is a prerequisite for reliable estimates of the secondary structure content. Overlay ofthe CD spectra ofPrP-wt and PrP 11114-121 revealed that the latter exhibited more intense bands around 190 nm and 208 nm, but not at 222 nm (Fig. 4A) . The constant intensity of the CD bands at 222 nm, where only a-helices contribute significantly, suggests that the content of a,-helix did not change. The bands at 208 and 190 nm, on the other hand, contain spectral contributions from f,-sheets, f:,>-tums and random coil [27] . The calculated difference spectrum of PrP1l114-121 minus PrP-wt resembles closely the spectrum of I:,>-sheet structures computed from CD spectra of 15 different proteins [23] underlining that an additional f,-sheet has formed (Fig. 4B) . For a quantification ofthe secondary structure in PrPwt and PrPIl114-121, the spectra were analyzed according to Chang et al. [23] and with the programs SELCON [25] , CONTINLL [26] and CDSSTR [27] . The analysis revealed again a higher f,-sheet content in PrPIl114-121, thus corroborating the results form FTIR spectroscopy. The results from FTIR and CD analysis are compared in Table 2 .
Overall, the estimates of the secondary structure content by both spectroscopic techniques, FTIR and CD, are in good agreement. Noteworthy, both methods reveal that the deletion of re si dues 114-121 in PrP lead to an increase of 2-3% in r~ sheet content, and a concomitant 1-3% decrease in random coil, whereas the a-helix content stays constant. The data demonstrate, that a part of the unstructured N-terminal domain of PrP-wt has converted into [,,>-sheet in PrP 11114-121. The 2-3% higher content of r)-sheet of secondary structure elements corresponds to four additional residues forming Wavelength I nm Wavelength / nm 
Analysis of protein stability by chemical denaturation
. PrP-wt and PrP Ll114-121 were unfolded by increasing concentrations of the denaturing agent GdnHCl, and the eIlipticity at 222 nm was recorded. The unfolding/folding of the C-terminal structured domain ofPrP is fully reversible under these conditions [36] . The denaturation curves for both proteins are shown in Fig. 5 . Analysis of the data by a least-square fit [29] yielded the difference in free energy LlGo between folded and unfolded state. For PrP-wt a AGo of 2l.4±0.3 kJ mol-) was determined. A significantly higher stability with LlG o equaling to 24.8±OA kJ moll was found for PrPLl1I4-12l. The LlLlG o of 3A±0.3 kJ moll would account for 1-2 additional hydrogen bonds in PrP LlI14-121. Thus, the deletion of the amino acids 114-121 in PrP results in a stabilization of the overall protein structure.
EPR spectroscopic analysis of copper(JI) binding to PrP-wt andPrPATM
The deleted residues 114-121 in PrP are located very closely to a Cu 2 + binding site that is remote from the octarepeat Comparison of CD and FTIR data. structure [9, 37] . This site coordinates Cu2+ through the imidazole nitrogen of His 111 (His 11 0 in mouse PrP) and most likely through backbone nitrogen or one methionine sulphur [38] [39] [40] . In competition experiments it was shown that pep tides encompassing the TM 1 domain (aa 91-115) bind Cu 2+ with higher affinity than the octarepeats (aa 58-91) [9] . Cu 2 + binding to this site induces f:,>-sheet formation [9] and conversion of Prp c into a protease-resistant species [41] . The peptide PrP 106-126 which harbors this Cu 2 +-binding site, is cytotoxic [14, 42, 43] 
to Prp c -expressing cells, and this sequence is essential for the conversion of Prp c into Prp
sc [44] .
Interestingly, Cu
2 + binding to this peptide promotes aggregation and the formation of fibrils [45] .
We examined the effects of deleting residues 114-121 on the binding of Cu 2 + to Prp c by EPR spectroscopy. Only 0.9 equivalents ofCu 2 + per PrP-wt or PrPA114-121 were added. As this site displays higher affinity to CU 21 than do the octarepeats, the added Cu 2 + binds predominantly there [9] . EPR spectra of Cu 2 + -bound PrP-wt and CU 21 -bound PrPLl1I4-121 were typical of type 11 Cu in a square planar geometry [46] . Both Cu-protein complexes exhibited the same g and A parameters, gll=2.26, AII= 17 mTand in the g.l region a crossover at g=2.06. There were some differences in the g.l region (Fig. 6A, B further analyzed by taking the derivative ofthe recorded spectra to resolve for additional splittings from coordinated nitrogens (1= 1 for tAN). At least seven equidistant lines could be resolved This is in agreement with a recent study on Cu 2 + -binding to the PrP 90-126 peptide [47] and further supported by a EXAFS study which suggests that Cu 2 + is coordinated by one Sand three N atoms to the PrP 106-114 peptide [39, 40] . In summary, the Cu 2 + binding to the PrP protein was marginally affected, if at all, by the deletion of residues 114-121.
Discussion
In this study, we investigated the influence of the deleting residues 114-121 of mouse PrP on protein structure, stability and Cu 2 + binding properties. Previous work in scrapie-infected cell cultures had shown that this deletion mutant is resistant to conversion into Prp sc [17] . FTIR spectroscopic analysis in this study revealed a higher content of Il,-sheet structure in the mutant protein. The CD spectra obtained in the present study are very similar to those of mouse PrP 23-231 or human PrP 23-231 in previous studies [21, 34] and the CD intensity at 222 nm of-8.000 to -9.000 deg dmol-I cm 2 demonstrate a content of 20-22% a-helix in PrP-wt (23-231). Thus, the proteins prepared in the different studies have the same secondary structure content. By contrast, the secondary structure content of mouse PrP as derived from the NMR structure of mouse PrP 121-231 [33] and assuming that the N-terminal region 23-121 is not folded yields about 27.7% a-helical content. Clearly, the secondary structure content calculated by CD and FTIR spectroscopy deviates from the structure determined by NMR spectroscopy. The difference is more pronounced comparing the l3-sheet content of Prp c calculated by CD and FTIR spectroscopy with the structural data. Again, assuming that the Nterminal part of PrP-wt (23-121) contains no l3-sheet, one calculates the Il,-sheet content from the NMR structural data to 2%, whereas the CD and FTIR spectroscopic data strongly support a r)-sheet content of25-28%. The content ofl3-tums in the structures of mouse Prp c 23-231 was judged from the structural information on mouse Prp c 121-231 and from the structural data of three octarepeats (human PrP 61-84) determined by NMR [48] using the program STRIDE [49] . Table 2 ). The largest uncertainty in the calculation of the secondary stmcture content arises from the lack of structural data for the N-tertninal region. Two NMR studies have shown that this region does not adopt a complete random coil conformation. Especially the octarepeat regions form ~>,-tums [48] , and further regions in the N-terminus encompassing at least 10 more residues exist in mixed populations of random coil and a structured state [50] . However, the apparent deviation in secondary structure content determined by NMR and calculated from CD and FTIR spectra is most likely due to incorrect assignments of [:',-tum and ~-sheet transition bands in FTIR as well as in CD spectroscopy. We performed our fits and assignments of FTIR bands in agreement with recent FTIR studies on PrP [51] [52] [53] or general studies on protein secondary structure analysis [54] . However, there is also a detailed spectroscopic study on rHums, where the authors assign a band around 1640 cm-I of the amide I region (i.e. ~ 1635 cm-I in D 2 0) to [:>,-tum instead to ~)-sheets [55] . The situation is similar in CD spectroscopy. A study showed that the r~-tums type I and type II contribute differently to the CD spectrum and can largely overlay the bands of [:>,-sheet structures [56] . Therefore the quantification of all secondary structure components by FTIR and CD spectroscopy remains difficult. Nevertheless, the comparison ofthe spectra of Prp c -wt and PrP ~ 114-121 yields valuable information on structural changes in the deletion mutant. We identified an increase of a band centered at 1615 cm-I in the amide I' region ofPrP~114-121 (Fig. 3) . The assignment of this band· to antiparaIlel ~)-sheets is well established and is evidence for an additional short f>,-sheet in PrPA114-121. In general, antiparallel [:',-sheets are more reliably estimated from FTIR spectra than from CD spectra [54] . The analysis of the CD spectra ofPrP-wt and PrP~114-121 (Fig. 4B ) supports this observation ( Table 2 ). The formation of a short ~-sheet encompassing residues 110-112 in PrPA114-121 is also suggested by nnPredict (Fig. 3) . It is in proximity to 0-sheet 1 and might arrange antiparaIlel to this structure, thus stabilizing this region as confirmed by unfolding experiments using chemical denaturation (Fig. 5) . The folding energy of PrP-wt 23-231 of -21A±0.3 kJ mol-1 was very similar to the value determined by Homemann and Glockshuber [36] for PrP 121-231 with ~Go=-21.8±1.4 kJ mol-I at pH 7.0 in 20 mM sodium phosphate buffer, suggesting that the Nterminal region does not significantly contribute to the overall stability of the protein. The increased stability ofprP ~ 114-121 with a folding energy of -24.8±OA kJ moll accounts for approximately I or 2 additional hydrogen bonds, as expected by the formation of a short strand of anti parallel f3-sheet.
The small changes in the overall structure of PrP ~ 114-121 compared to PrP-wt argue for an at least partial preservation of PrP's physiological function. This is supported by our recent observation that expression of PrP~1l4-121 in mice on a Prp -/-background, which did not cause any pathogenic effect by itself, diminished the pathogenic effect of the deletion mutant PrP~32-134 in transgenic mice [19] although the rescue effect was weaker than that of PrP-wt [57, 58] . In stark contrast, co-expression of PrP ~ 114-121 aggravated the pathogenic effect of another deletion mutant, PrP ~ 94-134 (termed PrP ~CD), that is rescued by PrP-wt [19] , which is clear evidence for a fundamental difference between PrP~114-121 and PrP-wt at the functional level. Interestingly, our recent topology studies revealed that deletion of residues 114-121 leads to the complete loss of the transmembrane topology and of CY-cleavage of Prp c [59] .
The structural changes in PrP ~ 114-121 discovered in the present wolk point to two possible mechanisms of how the deletion of residues 114-121 might abolish the conversion into Prp sc • The first possibility is that the region around the deletion is required for transient destabilization followed by structural conversion of Prp c into Prp sc as indicated by several studies [17, 18, 44, 60] . The minimal infectious unit is represented by Prp sc that is based on the conversion of "Prp c 1 06", representing a molecule with deletion of both, residues 23-88 and 141-176, yet comprising the region 90-121 [16] . The second possibility of how the conversion of PrP ~ 114-121 into Prp sc might be blocked is the loss of the binding site between Prp c and Prp sc . Association between Prp c and Prp sc is required for the conversion of Prp c and Prp sc accumulation. Norstrom and Mastrianni [18] presented evidence that the palindromic sequence AGAAAAGA (residues 112-119) is necessary for the binding of Pr pC to Prp sc . One cannot exclude that the binding occurs also via neighboring residues close to the palindromic sequence. We observed that the deletion of residues 114-121 led to the formation of a short ~-sheet most likely close to this site. Deletion of re si dues 112-119 may well result in a similar structural change. Such a conformational change might cover the recognition site between PrpC: and Prp sc and therefore block the conversion ofPrP~ 114-121 into Prp sc . However, the second possibility describing the loss of the binding site in PrP ~ 114-121 cannot explain the observed phenotype of a dominant-negative effect on prion propagation [17] . The first model presented above including an additional ~>,-sheet that energetically blocks the conversion of PrP A 114-121 into Prp sc can indeed provide an explanation for the observed dominant-negative effect. The overall similar structure between PrPA114-121 and PrPC-wt stilI enables the binding of the mutant to Prp sc . The deletion, however, renders the molecule inert with respect to the conversion process. This will break the chain of Prp sc accumulation and should ultimately prevent disease progression. Future prion inoculation studies of the transgenic mice carrying the PrPA114-121 gene [19] will be instrumental to verify in vivo the model proposed here.
